375 related articles for article (PubMed ID: 34066907)
1. Properties of Non-Aminoglycoside Compounds Used to Stimulate Translational Readthrough of PTC Mutations in Primary Ciliary Dyskinesia.
Dabrowski M; Bukowy-Bieryllo Z; Jackson CL; Zietkiewicz E
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066907
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycoside-stimulated readthrough of premature termination codons in selected genes involved in primary ciliary dyskinesia.
Bukowy-Bieryllo Z; Dabrowski M; Witt M; Zietkiewicz E
RNA Biol; 2016 Oct; 13(10):1041-1050. PubMed ID: 27618201
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development.
Li S; Li J; Shi W; Nie Z; Zhang S; Ma F; Hu J; Chen J; Li P; Xie X
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371567
[TBL] [Abstract][Full Text] [Related]
4. Small molecule Y-320 stimulates ribosome biogenesis, protein synthesis, and aminoglycoside-induced premature termination codon readthrough.
Hosseini-Farahabadi S; Baradaran-Heravi A; Zimmerman C; Choi K; Flibotte S; Roberge M
PLoS Biol; 2021 May; 19(5):e3001221. PubMed ID: 33939688
[TBL] [Abstract][Full Text] [Related]
5. Aminoglycosides are efficient reagents to induce readthrough of premature termination codon in mutant B4GALNT1 genes found in families of hereditary spastic paraplegia.
Yesmin F; Bhuiyan RH; Ohmi Y; Ohkawa Y; Tajima O; Okajima T; Furukawa K; Furukawa K
J Biochem; 2020 Aug; 168(2):103-112. PubMed ID: 32282910
[TBL] [Abstract][Full Text] [Related]
6. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
[TBL] [Abstract][Full Text] [Related]
7. Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity.
Baradaran-Heravi A; Niesser J; Balgi AD; Choi K; Zimmerman C; South AP; Anderson HJ; Strynadka NC; Bally MB; Roberge M
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3479-3484. PubMed ID: 28289221
[TBL] [Abstract][Full Text] [Related]
8. Characterization of new-generation aminoglycoside promoting premature termination codon readthrough in cancer cells.
Bidou L; Bugaud O; Belakhov V; Baasov T; Namy O
RNA Biol; 2017 Mar; 14(3):378-388. PubMed ID: 28145797
[TBL] [Abstract][Full Text] [Related]
9. Effect of small molecule eRF3 degraders on premature termination codon readthrough.
Baradaran-Heravi A; Balgi AD; Hosseini-Farahabadi S; Choi K; Has C; Roberge M
Nucleic Acids Res; 2021 Apr; 49(7):3692-3708. PubMed ID: 33764477
[TBL] [Abstract][Full Text] [Related]
10. Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides.
Wangen JR; Green R
Elife; 2020 Jan; 9():. PubMed ID: 31971508
[TBL] [Abstract][Full Text] [Related]
11. Systematic and quantitative analysis of stop codon readthrough in Rett syndrome nonsense mutations.
Lebeda D; Fierenz A; Werfel L; Rosin-Arbesfeld R; Hofhuis J; Thoms S
J Mol Med (Berl); 2024 May; 102(5):641-653. PubMed ID: 38430393
[TBL] [Abstract][Full Text] [Related]
12. Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons.
Kuschal C; DiGiovanna JJ; Khan SG; Gatti RA; Kraemer KH
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19483-8. PubMed ID: 24218596
[TBL] [Abstract][Full Text] [Related]
13. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency.
Frew J; Baradaran-Heravi A; Balgi AD; Wu X; Yan TD; Arns S; Shidmoossavee FS; Tan J; Jaquith JB; Jansen-West KR; Lynn FC; Gao FB; Petrucelli L; Feldman HH; Mackenzie IR; Roberge M; Nygaard HB
Mol Neurodegener; 2020 Mar; 15(1):21. PubMed ID: 32178712
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic readthrough strategy for suppression of nonsense mutations in duchenne muscular dystrophy].
Shiozuka M; Matsuda R
Brain Nerve; 2011 Nov; 63(11):1253-60. PubMed ID: 22068478
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system.
Keeling KM; Bedwell DM
J Mol Med (Berl); 2002 Jun; 80(6):367-76. PubMed ID: 12072912
[TBL] [Abstract][Full Text] [Related]
16. Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesia.
Lee DDH; Cardinale D; Nigro E; Butler CR; Rutman A; Fassad MR; Hirst RA; Moulding D; Agrotis A; Forsythe E; Peckham D; Robson E; Smith CM; Somavarapu S; Beales PL; Hart SL; Janes SM; Mitchison HM; Ketteler R; Hynds RE; O'Callaghan C
Eur Respir J; 2021 Oct; 58(4):. PubMed ID: 33795320
[TBL] [Abstract][Full Text] [Related]
17. Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons.
Dabrowski M; Bukowy-Bieryllo Z; Zietkiewicz E
Mol Med; 2018 May; 24(1):25. PubMed ID: 30134808
[TBL] [Abstract][Full Text] [Related]
18. Effect of Readthrough Treatment in Fibroblasts of Patients Affected by Lysosomal Diseases Caused by Premature Termination Codons.
Matalonga L; Arias Á; Tort F; Ferrer-Cortés X; Garcia-Villoria J; Coll MJ; Gort L; Ribes A
Neurotherapeutics; 2015 Oct; 12(4):874-86. PubMed ID: 26169295
[TBL] [Abstract][Full Text] [Related]
19. Nonsense suppression therapies in human genetic diseases.
Martins-Dias P; Romão L
Cell Mol Life Sci; 2021 May; 78(10):4677-4701. PubMed ID: 33751142
[TBL] [Abstract][Full Text] [Related]
20. Factors Affecting Readthrough of Natural Versus Premature Termination Codons.
Beryozkin A; Nagel-Wolfum K; Banin E; Sharon D
Adv Exp Med Biol; 2023; 1415():149-155. PubMed ID: 37440028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
